Eurofins Discovery and Invasight partner to advance cancer therapies
The partnership will work to develop first-in-class, small molecule, protein-protein interaction antagonists (PPIAs) against a protein that causes…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Feb 23
The partnership will work to develop first-in-class, small molecule, protein-protein interaction antagonists (PPIAs) against a protein that causes…
14 Feb 23
The multi-year, multimillion-pound drug discovery research collaboration intends to discover new drugs for neurodegenerative disease treatment
13 Feb 23
The label expansion of CIBINQO was supported by the data from the phase 3 JADE TEEN clinical trial…
10 Feb 23
QuantalX’s direct electrophysiology imaging technology (Delphi-MD) expected to provide multiple clinically objective and accurate measurements in NeuroSense's Phase…
10 Feb 23
Vertex Pharmaceuticals will be in charge of the global development, production, and marketing of Entrada Therapeutics’ ENTR-701 as…
09 Feb 23
GA Health pioneered the design of suction valves, creating one stronger than other models
09 Feb 23
Upon closing of the transaction, Oak Street Health will become part of CVS Health's recently established Health Care…
09 Feb 23
The approval was based on data from two randomised phase 3 trials that assessed the VEGF inhibitor in…
08 Feb 23
Since the end of 2022, COVID-19 has entered a new stage, becoming part of a group of routine…
08 Feb 23
Results of the late-stage study demonstrated that crovalimab administered as a subcutaneous injection every four weeks, controlled the…